Please login to the form below

Not currently logged in
Email:
Password:

NICE appoints Mark Baker and Alexia Tonnel as directors

Baker becomes director of the centre for clinical practice while Tonnel takes over as director of evidence resources

The UK's National Institute for Health and Clinical Excellence (NICE) has appointed Professor Mark Baker and Alexia Tonnel as directors.

Prof Baker will replace the departing Prof Peter Littlejohns as director of the centre for clinical practice, while Tonnel will take over the role of director of evidence resources following the retirement of Dr Fergus Macbeth.

Both new directors have previously worked for NICE, which evaluates a product's cost-effectiveness and sets clinical guidance in the NHS, for several years.

Prof Baker has been involved with the NICE Guidelines Programme for nearly a decade, has worked as a consultant adviser to the body since 2009, and has chaired two clinical guideline development groups.

His previous experience in healthcare includes serving as chief executive of Bradford Teaching Hospitals and medical director at North Yorkshire health authority, West Yorkshire strategic health authority and Leeds Teaching Hospitals.

Tonnel has been a programme director at NICE since 2010, redesigning and managing the processes for the provision of content into NHS Evidence, the online health information portal NICE runs, and leading the development of new products, including Evidence Updates.

Prior to joining NICE, Tonnel was director at professional services firms Deloitte, advising clients in the life sciences and healthcare industries.

Sir Andrew Dillon, chief executive of NICE, said of the appointments: “Both have a wealth of experience in their respective fields and I am looking forward to working with them.”

8th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Synergy Vision

Synergy Vision believe in delivering medical communications that make a difference to healthcare professionals and patients. Our synergy of pharma...

Latest intelligence

Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...
Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...

Infographics